Clinical Trial Update: Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload [NA]

View source ↗

Summary

A clinical trial evaluating ultrafiltration (Aquapheresis) in patients with leukemia and severe fluid overload has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Aquapheresis Ultrafiltration (Ultrafiltration)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | NA | Status: WITHDRAWN